Bronchiectasis Clinical Trials

A listing of Bronchiectasis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 101 clinical trials
featured
A Study to Assess the Efficacy, Safety, and Tolerability of Brensocatib in Participants With Non-Cystic Fibrosis Bronchiectasis (ASPEN)

This study will investigate the efficacy, safety, and tolerability of brensocatib in the clinical management of subjects with Non-Cystic Fibrous Bronchiectasis (NCFBE).

bronchiectasis
  • 0 views
  • 29 Jul, 2021
  • 1 location
Trial in Non-cystic Fibrosis Bronchiectasis Patients With Chronic Lung Infections Treated With Colistimethate Sodium (PROMIS II)

subjects with non-cystic fibrosis bronchiectasis (NCFB) chronically infected with P. aeruginosa on the frequency of pulmonary exacerbations.

  • 155 views
  • 24 Jan, 2021
  • 108 locations
A Study to Assess the Efficacy Safety and Tolerability of Brensocatib in Participants With Non-Cystic Fibrosis Bronchiectasis

The primary objective of this study is to evaluate the effect of brensocatib at 10 mg and 25 mg compared with placebo on the rate of pulmonary exacerbations (PEs) over the 52-week treatment period.

  • 3 views
  • 01 Aug, 2021
  • 254 locations
Home Airway Clearance in Patients With Bronchiectasis (Home-Care Bronchiectasis)

Bronchiectasis is a chronic multiple etiologies pulmonary disease characterized by permanent dilatation of the caliber of the bronchial tree territory with an alteration of mucociliary clearance

  • 0 views
  • 05 Jun, 2021
  • 3 locations
Bacteriology and Inflammation in Bronchiectasis

Bronchiectasis is a chronic disease arises from progressive airway inflammation and infection. It has been postulated that bacterial infection triggers intense airway inflammation leading to

bacterial infection
acute exacerbation of bronchiectasis
antibiotics
antibiotic therapy
  • 33 views
  • 23 Jan, 2021
  • 1 location
Roflumilast in Non-CF Bronchiectasis Study (2019)

This is a single-arm, open label, Phase II study of 12-week use of Roflumilast in stable-state non-cystic fibrosis bronchiectasis subjects. Bronchiectasis refers to a suppurative lung

  • 0 views
  • 10 May, 2021
  • 1 location
Effect of AIRVO Heated Humidification in Bronchiectasis

exacerbations in adults with non-cystic fibrosis bronchiectasis.

  • 12 views
  • 24 Jan, 2021
  • 33 locations
Randomised Open Label Trial of Hypertonic Saline and Carbocisteine in Bronchiectasis (CLEAR)

Patients with bronchiectasis (BE) suffer from a persistent cough, daily sputum expectoration, recurrent chest infections, and a poor health-related quality of life. Current guidelines for the

  • 0 views
  • 23 Jan, 2021
  • 11 locations
Trial on The Efficacy of Hypertonic Saline on Non-CF CSLD.

To determine the efficacy of nebulized 5% hypertonic saline on cough severity and quality of life, in children with non-CF CSLD. Secondary Aims: To determine the: Efficacy of nebulized 5% hypertonic saline on airway microbiome, pulmonary exacerbation rate, healthcare utilization, and rescue antibiotics. Efficacy of nebulized 5% hypertonic saline on …

  • 0 views
  • 02 Mar, 2021
  • 1 location
Sputum Microbiota and the Association With Clinical Parameters in Steady-state Acute Exacerbation and Convalescence of Bronchiectasis

Study 1 is a cross-sectional investigation. Patients with clinically stable bronchiectasis (symptoms, including cough frequency, sputum volume and purulence, within normal daily variations) will

grip
cough
spirometry
antibiotics
antibiotic therapy
  • 27 views
  • 23 Jan, 2021
  • 1 location